Proxalutamide
Proxalutamide Uses, Dosage, Side Effects, Food Interaction and all others data.
Proxalutamide is under investigation in clinical trial NCT03899467 (The Safety and Tolerability of Proxalutamide (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer).
| Trade Name | Proxalutamide |
| Generic | Proxalutamide |
| Proxalutamide Other Names | Proxalutamide |
| Type | |
| Formula | C24H19F4N5O2S |
| Weight | Average: 517.5 Monoisotopic: 517.119558698 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How Proxalutamide works
Proxalutamide is an antagonist at the androgen receptor which leads to inhibition of androgen-induced receptor activation and results in formation of inactive complexes that are not able to translocate to the nucleus. It also induces androgen receptor downregulation, furthering adrogen-induced receptor activation. This drug is being investigated for its potential antineoplastic activity and is being investigated specifically against prostate cancer and COVID-19.
Innovators Monograph
You find simplified version here Proxalutamide
